¼¼°èÀÇ ±¹¼Ò â»ó Ä¡·áÁ¦ ½ÃÀå
Topical Wound Agents
»óǰÄÚµå : 1777628
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 367 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,195,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,585,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ±¹¼Ò â»ó Ä¡·áÁ¦ ½ÃÀåÀº 2030³â±îÁö 25¾ï ´Þ·¯¿¡ µµ´Þ

2024³â¿¡ 17¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ ±¹¼Ò â»ó Ä¡·áÁ¦ ½ÃÀåÀº 2024-2030³â¿¡ CAGR 6.7%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 25¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ Å©¸²Àº CAGR 8.6%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 11¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Á© ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ Áß CAGR 4.3%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 4¾ï 7,050¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 10.9%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ±¹¼Ò â»ó Ä¡·áÁ¦ ½ÃÀåÀº 2024³â¿¡´Â 4¾ï 7,050¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2024-2030³âÀÇ ºÐ¼® ±â°£¿¡ CAGR 10.9%¸¦ °ßÀÎÇϸç, 2030³â±îÁö 5¾ï 3,870¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 3.2%¿Í 6.6%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 4.4%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

±¹¼Ò â»ó Ä¡·áÁ¦ ½ÃÀåÀÇ µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

±¹¼Ò »óó Ä¡·áÁ¦´Â »óó Ä¡·á¿Í Á¶Á÷ Àç»ý¿¡ ¾î¶² Çõ¸íÀ» ÀÏÀ¸Å°°í Àִ°¡?

±¹¼Ò »óó Ä¡·áÁ¦´Â Çö´ë »óó Ä¡·á¿¡¼­ Á¡Á¡ ´õ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, °¨¿° ¹æÁö, Á¶Á÷ Àç»ý, Ä¡À¯ ÃËÁø µîÀÇ Ã·´Ü ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù. Ç×±Õ Å©¸², ¼ºÀåÀÎÀÚ ±â¹Ý Á©, ÇÏÀ̵å·ÎÄÝ·ÎÀÌµå µå·¹½Ì Àç·á, È¿¼Ò µ¥ºê¸®µå¸¸ Á¦Ç° µî ±Þ¼º ¹× ¸¸¼º »óó¸¦ È¿°úÀûÀ¸·Î °ü¸®ÇÒ ¼ö ÀÖµµ·Ï °í¾ÈµÈ ´Ù¾çÇÑ ¾àǰÀÌ ÀÖ½À´Ï´Ù. ´ç´¢º´¼º ±Ë¾ç, ¿åâ, È­»ó, ¼ö¼ú »óó Áõ°¡·Î ÀÎÇØ °í±Þ ±¹¼Ò »óó °ü¸® Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Ç×±ÕÁ¦ ³»¼º(AMR)ÀÇ ºÎ´ãÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Àº ±â¹Ý Á¦Á¦, ²Ü ±â¹Ý µå·¹½ÌÀç, ÆéƼµå ±â¹Ý Ç×±ÕÁ¦ µî »õ·Î¿î »ý¹°ÇÐÀû Ȱ¼º »óó Ä¡·áÁ¦ÀÇ °³¹ß¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ±×·¯³ª °í°¡ÀÇ Ä¡·áºñ, Àú¼Òµæ Áö¿ª¿¡¼­ÀÇ ³·Àº ÀÎÁöµµ, Á¦Ç° ½ÂÀο¡ ´ëÇÑ ±ÔÁ¦Àû Àå¾Ö¹° µîÀÌ ½ÃÀå È®´ëÀÇ °É¸²µ¹·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. »óó °ü¸®°¡ °³ÀÎ ¸ÂÃãÇü Àç»ý Á¢±Ù¹ýÀ¸·Î ÀüȯµÇ°í ÀÖ´Â °¡¿îµ¥, »ý¹°ÇÐÀû Ȱ¼º°ú ³ª³ëÅ×Å©³î·¯ÁöÀ» Ȱ¿ëÇÑ »óó Ä¡·áÁ¦ÀÇ ±â¼ú Çõ½ÅÀº »óó Ä¡·áÀÇ ¹Ì·¡¸¦ ¾î¶»°Ô º¯È­½Ã۴°¡?

±¹¼Ò »óó Ä¡·áÁ¦¸¦ ¹ßÀü½Ã۰í ÀÖ´Â ±â¼ú Çõ½ÅÀº ¾î¶² °ÍÀÌ Àִ°¡?

ÃÖ±Ù ±¹¼Ò »óó Ä¡·áÀÇ ¹ßÀüÀº Ä¡À¯ È¿°ú Çâ»ó, °¨¿° À§Çè °¨¼Ò, Ȱ¼º ¼ººÐÀÇ »ýü ÀÌ¿ë·ü Çâ»ó¿¡ ÃÊÁ¡À» ¸ÂÃß¾ú½À´Ï´Ù. ³ª³ëÅ×Å©³î·¯ÁöÀ» µµÀÔÇÑ µå·¹½Ì ¼ÒÀçÀÇ °³¹ß·Î Ç×±ÕÁ¦ÀÇ Á¦¾îµÇ°í Áö¼ÓÀûÀÎ ¹æÃâÀÌ °¡´ÉÇØÁ® ¸¸¼º »óóÀÇ Ä¡·á ¼ºÀûÀÌ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ¼ºÀåÀÎÀÚ ±â¹ÝÀÇ Áٱ⼼Æ÷ À¯·¡ »óó µå·¹½ÌÁ¦´Â Á¶Á÷ Àç»ýÀ» ÃËÁøÇϰí, ÈäÅÍ Çü¼ºÀ» °¨¼Ò½Ã۸ç, º¹ÀâÇÑ »óóÀÇ Ä¡À¯À²À» Çâ»ó½Ãŵ´Ï´Ù. ¹ÙÀÌ¿À ¼¾¼­°¡ ³»ÀåµÈ ½º¸¶Æ® »óó µå·¹½ÌÀº »óó »óŸ¦ ½Ç½Ã°£À¸·Î ¸ð´ÏÅ͸µÇÏ¿© Ä¡·áÀÇ Á¶Á¤À» ÃÖÀûÈ­ÇÕ´Ï´Ù. ¶ÇÇÑ ÆéƼµå ±â¹Ý Ç×±ÕÁ¦°¡ ±âÁ¸ Ç×»ýÁ¦¸¦ ´ëüÇÒ ¼ö ÀÖ´Â ´ë¾ÈÀ¸·Î µîÀåÇÏ¿© ¾àÁ¦ ³»¼º °¨¿°¿¡ ´ëÇÑ ¿ì·Á¸¦ ÇØ¼ÒÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Çõ½ÅÀº »óó °ü¸® Àü·«À» Å©°Ô °³¼±Çϰí, ȯÀÚÀÇ ÆíÀǼºÀ» ³ôÀ̸ç, ¸¸¼º »óó Ä¡·á¿Í °ü·ÃµÈ ÀÇ·á ºñ¿ëÀ» Àý°¨Çϰí ÀÖ½À´Ï´Ù.

±¹¼Ò »óó Ä¡·áÁ¦ ¼ö¿ä°¡ Áõ°¡ÇÏ´Â ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

´ç´¢º´¼º Á·ºÎ±Ë¾ç, ¿åâ, Á¤¸Æ¼º ÇÏÁö±Ë¾ç°ú °°Àº ¸¸¼º »óó°¡ Àü ¼¼°è¿¡¼­ Áõ°¡ÇÔ¿¡ µû¶ó ÷´Ü »óó °ü¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¼ö¼ú, ¿Ü»ó, È­»ó ȯÀÚ ¼ö°¡ Áõ°¡Çϰí ÀÖ´Â °Íµµ ½ÃÀå ¼ºÀå¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¿Ü·¡ ¹× ÀçÅà »óó Ä¡·á°¡ Áß¿äÇØÁö¸é¼­ Àû¿ëÀÌ °£ÆíÇϰí È¿°úÀûÀÎ ±¹¼Ò »óó Ä¡·áÁ¦ÀÇ Ã¤ÅÃÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¸¸¼º »óó¿Í Ä¡À¯ Áö¿¬À» À¯¹ßÇϱ⠽¬¿î ³ë·É Àα¸ Áõ°¡µµ Çõ½ÅÀûÀÎ »óó Ä¡·á Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

±¹¼Ò »óó Ä¡·áÁ¦ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

±¹¼Ò »óó Ä¡·áÁ¦ ½ÃÀåÀº »ý¹°ÇÐÀû Ȱ¼º »óó Ä¡À¯ ±â¼úÀÇ ¹ßÀü, ¸¸¼º »óó À¯º´·ü Áõ°¡, Àç»ýÀÇ·á¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡, Ç×±ÕÁ¦ ³»¼º °¨¿° Á¦¾î ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. »õ·Î¿î »óó Ä¡·áÁ¦ÀÇ ±ÔÁ¦ ½ÂÀΰú °³ÀÎ ¸ÂÃãÇü »óó Ä¡·á Á¢±Ù¹ýÀÇ Ã¤Åà Áõ°¡°¡ ½ÃÀåÀ» ´õ¿í Çü¼ºÇϰí ÀÖ½À´Ï´Ù. ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õµéÀÌ º¸´Ù ºü¸£°í È¿°úÀûÀÎ »óó Ä¡À¯¸¦ ÃÖ¿ì¼± °úÁ¦·Î »ï°í ÀÖ´Â °¡¿îµ¥, ±¹¼Ò »óó Ä¡·áÁ¦´Â Çö´ë »óó °ü¸®ÀÇ ÇʼöÀûÀÎ ¿ä¼Ò·Î ±Þ¼º ¹× ¸¸¼º »óó ȯÀÚÀÇ °á°ú¸¦ °³¼±ÇÒ °ÍÀ¸·Î ±â´ëµË´Ï´Ù.

ºÎ¹®

Á¦Ç°(Å©¸², Á©, ½ºÇÁ·¹ÀÌ, ±âŸ); ¿ëµµ(¸¸¼º â»ó, ±Þ¼º â»ó); ÃÖÁ¾ ¿ëµµ(º´¿ø, Ŭ¸®´Ð, ±âŸ)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹

AI ÅëÇÕ

¿ì¸®´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI Åø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM³ª ¾÷°èº° SLM Äõ¸®¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ´ë·® ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÔ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Topical Wound Agents Market to Reach US$2.5 Billion by 2030

The global market for Topical Wound Agents estimated at US$1.7 Billion in the year 2024, is expected to reach US$2.5 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. Creams, one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach US$1.1 Billion by the end of the analysis period. Growth in the Gels segment is estimated at 4.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$470.5 Million While China is Forecast to Grow at 10.9% CAGR

The Topical Wound Agents market in the U.S. is estimated at US$470.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$538.7 Million by the year 2030 trailing a CAGR of 10.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.2% and 6.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Topical Wound Agents Market Trends & Drivers Summarized

How Are Topical Wound Agents Revolutionizing Wound Care and Tissue Regeneration?

Topical wound agents are playing an increasingly vital role in modern wound care, offering advanced solutions for infection control, tissue regeneration, and accelerated healing. These agents include antimicrobial creams, growth factor-based gels, hydrocolloid dressings, and enzymatic debridement products, designed to manage acute and chronic wounds effectively. The rising prevalence of diabetic ulcers, pressure sores, burns, and surgical wounds is driving demand for advanced topical wound care products. Additionally, the increasing burden of antimicrobial resistance (AMR) has fueled the development of novel bioactive wound agents, including silver-based formulations, honey-based dressings, and peptide-based antimicrobials. However, challenges such as high treatment costs, limited awareness in low-income regions, and regulatory hurdles in product approvals remain obstacles to market expansion. As wound management shifts toward personalized and regenerative approaches, how will innovations in bioactive and nanotechnology-driven wound agents reshape the future of wound care?

What Technological Innovations Are Advancing Topical Wound Agents?

Recent advancements in topical wound care focus on improving healing efficacy, reducing infection risks, and enhancing bioavailability of active ingredients. The development of nanotechnology-infused dressings is enabling controlled and sustained release of antimicrobial agents, improving treatment outcomes for chronic wounds. Growth factor-based and stem cell-derived wound agents are accelerating tissue regeneration, reducing scarring, and improving healing rates for complex wounds. Smart wound dressings with embedded biosensors are allowing real-time monitoring of wound conditions, optimizing treatment adjustments. Additionally, peptide-based antimicrobial agents are emerging as alternatives to traditional antibiotics, addressing concerns over drug-resistant infections. These innovations are significantly improving wound management strategies, enhancing patient comfort, and reducing healthcare costs associated with chronic wound care.

Why Is the Demand for Topical Wound Agents Increasing?

The rising global incidence of chronic wounds, including diabetic foot ulcers, pressure ulcers, and venous leg ulcers, is driving demand for advanced wound care solutions. The increasing number of surgical procedures, traumatic injuries, and burn cases is further fueling market growth. Additionally, the growing emphasis on outpatient and home-based wound care is expanding the adoption of easy-to-apply, effective topical wound agents. The expanding geriatric population, which is more susceptible to chronic wounds and slow healing, is also contributing to increased demand for innovative wound healing products.

What Factors Are Driving the Growth of the Topical Wound Agents Market?

The market for topical wound agents is growing due to advancements in bioactive wound healing technologies, increasing prevalence of chronic wounds, rising investments in regenerative medicine, and the demand for antimicrobial-resistant infection control solutions. Regulatory approvals for novel wound agents and increasing adoption of personalized wound care approaches are further shaping the market. As healthcare providers continue to prioritize faster, more effective wound healing, topical wound agents are expected to become an integral component of modern wound management, improving outcomes for patients with acute and chronic wounds.

SCOPE OF STUDY:

The report analyzes the Topical Wound Agents market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Creams, Gels, Sprays, Others); Application (Chronic Wounds, Acute Wounds); End-Use (Hospitals, Clinics, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â